Louis A. Matis
2018
In 2018, Louis A. Matis earned a total compensation of $1.1M as Chief Development Officer at Pieris Pharmaceuticals, a 58% increase compared to previous year.
Compensation breakdown
| Bonus | $133,238 |
|---|---|
| Option Awards | $574,267 |
| Salary | $391,875 |
| Other | $24,789 |
| Total | $1,124,169 |
Matis received $574.3K in option awards, accounting for 51% of the total pay in 2018.
Matis also received $133.2K in bonus, $391.9K in salary and $24.8K in other compensation.
Rankings
In 2018, Louis A. Matis' compensation ranked 8,617th out of 14,244 executives tracked by ExecPay. In other words, Matis earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,617 out of 14,244 | 40th |
Division Manufacturing | 3,437 out of 5,762 | 40th |
Major group Chemicals And Allied Products | 1,301 out of 2,125 | 39th |
Industry group Drugs | 1,087 out of 1,814 | 40th |
Industry Pharmaceutical Preparations | 848 out of 1,388 | 39th |
Source: SEC filing on June 18, 2019.
Matis' colleagues
We found two more compensation records of executives who worked with Louis A. Matis at Pieris Pharmaceuticals in 2018.